Breakthrough Studies Demonstrate Stem Cell-Based Technologies as a Potential Alternative Treatment for Type 1 Diabetes
CHICAGO, June 20, 2025 /PRNewswire/ -- Findings from two studies...
New Studies Highlight Machine Learning as Potential Early Risk Detection Strategy
CHICAGO, June 20, 2025 /PRNewswire/ -- Developments from two studies highlighting the potential for machine...
Hybrid closed-loop technology effectively helped women stay in target glucose range for longer compared to standard of care
CHICAGO, June 20, 2025 /PRNewswire/ -- A...
Symposium previews new content for Standards of Care in Overweight and Obesity, designed to improve patient care and outcomes
CHICAGO, June 20, 2025 /PRNewswire/...
ASJ Open Forum Earns Second Consecutive Score, Signaling Steady Growth
GARDEN GROVE, Calif., June 20, 2025 /PRNewswire/ -- The Aesthetic Society is proud to announce a...
NEW HAVEN, Conn., June 20, 2025 /PRNewswire-HISPANIC PR WIRE/ -- Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a...
NEW HAVEN, Conn., June 20, 2025 /PRNewswire/ -- Yale School of Medicine (YSM) announces the launch of the Yale Biomedical Imaging Institute, a cross-disciplinary hub that...
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care
HealthRX enhances online platform to offer doctor-prescribed GLP-1 medications like Ozempic® and Zepbound® for adults seeking virtual weight loss support, prescription access, and 24/7 telehealth care
MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced the granting of inducement awards to one new non-executive employee as described below. In accordance with NASDAQ Listing Rule 5635(c)(4), these awards were approved by Neuronetics’ Compensation Committee and made as a material inducement to their respective employment with the Company. In all cases, vesting is subject to the recipient’s continued service with the Company through the applicable vesting date, and the awards are subject to the terms of the Company’s 2020 Inducement Incentive Plan.
Research Published in NEJM Evidence and presented at the International Conference on Malignant Lymphoma
NEW BRUNSWICK, N.J. and BOSTON, June 19, 2025 /PRNewswire/ -- Researchers from...
First FDA-cleared smart ring for multi-night sleep testing and 24/7 biometrics — to catch disease early—years before standard care.
AUSTIN, Texas, June 19, 2025 /PRNewswire/...
TEL AVIV, Israel, June 18, 2025 /PRNewswire/ -- MedHub-AI, a global leader in AI-powered cardiovascular diagnostics, announced today that the Pharmaceuticals and Medical Devices Agency...